SCHEMBL28758142

SCHEMBL28758142

CC(C)(C)C(=O)Oc1c[nH]c2ccc(OCCCBr)cc12

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HTR1B P28222 13/20 0.49
HTR1D P28221 11/20 0.49
HTT P42858 1/20 0.46
HTR1A P08908 11/20 0.42
MTNR1A P48039 3/20 0.41
MTNR1B P49286 3/20 0.41
KDM4E B2RXH2 2/20 0.40
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
HTR2A P28223 1/20 0.39
MAPK1 P28482 1/20 0.39
CYP2C19 P33261 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27752472 0.81 LTA4H (0.57) HTR1BHTR1DKDM4ECYP1A2CYP3A4
SCHEMBL27623612 0.80 KDM4E (0.54) KDM4ECYP1A2HTR2AMAPK1
SCHEMBL27596759 0.80 HTR1D (0.46) HTR1BHTR1D
SCHEMBL27584061 0.79 HTR1D (0.46) HTR1BHTR1D
SCHEMBL27751359 0.77 NR4A2 (0.52) HTR1BHTR1DMTNR1AMTNR1B
SCHEMBL28034299 0.77 HTT (0.57) HTR1BHTR1DHTTHTR1AMTNR1A
SCHEMBL28034417 0.76 HTT (0.56) HTR1BHTR1DHTTHTR1AMTNR1A
SCHEMBL27591862 0.75 NR4A2 (0.52) HTR1BHTR1DMTNR1AMTNR1BHTR2A
SCHEMBL27752468 0.75 HTR1D (0.45) HTR1BHTR1DHTR1AMTNR1AMTNR1B
SCHEMBL27667193 0.75 HTR1D (0.50) HTR1BHTR1DHTR1AKDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1738814-A Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER PHARMACEUTICALS CORP (US) 2006-02-22 CN disclosed